Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Fierce Pharma
BMS taps Anthropic’s Claude for enterprise-wide AI adoption
The deal will put Claude’s advanced reasoning and agentic capabilities in the hands of more than 30,000 BMS employees.
Angus Liu
May 20, 2026 10:16am
BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed
May 12, 2026 1:56am
From R&D to M&A: Big Pharmas showcase ‘measurable impact’ of AI
May 7, 2026 9:10am
Foundation Medicine links with Fulgent Genetics on new gene test
May 5, 2026 8:47am
BMS calls time on Zymeworks collab, ending work on bispecific
Apr 30, 2026 10:22am
Foundation Medicine expands BMS collab with new diagnostic target
Apr 21, 2026 7:16am
